Vaccine Inequity With Dr. Leonard Friedland
In this first episode of Contagion Community, we interview vaccine research scientist Dr. Leonard Friedland about vaccination disparities in the US and around the world.
Welcome to Contagion’s new podcast, Contagion Community, where we delve into some of the social factors that create and widen healthcare disparities.
In surveying our audience, 75% of respondents viewed health equity as a major issue within medicine. Infectious disease often disproportionately occurs along the lines of ethnicity, race, class, gender, education, sexual orientation, geographic location, and more. The entwined nature of healthcare inequity and social factors inhibit us from examining infectious disease objectively, which is why Contagion Community spotlights underserved populations.
Through interviews with experts, we will offer insights into the issues associated with healthcare inequities and examine the strategies being deployed to overcome them.
Contagion Community is a marriage of major conversations occurring in hospitals, labs, academics, and communities.
Vaccines have the power to save lives. However, what happens when they're not distributed equitably?
Today, Associate Editor Nina Cosdon speaks with Leonard Friedland, MD, vice president of Scientific Affairs and Public Health Vaccines at GlaxoSmithKline, about vaccine disparities in the US and around the world.
Enjoy the program and stay tuned for our next episode!
Listen in on the conversation and feel free to offer your feedback on this episode, interest in participating in the podcast, or suggest ideas for future episodes. Please email your correspondence to Nina Cosdon: ncosdon@mjhlifesciences.com.
